EFFECT OF METABOLIC DISORDERS IN THE COURSE OF OSTEOARTHRITIS

Cover Page


Cite item

Full Text

Abstract

The aim of this study was to examine the influence of obesity on the course of osteoarthritis (OA) in women. Material and methods: 83 women diagnosed with OA were divided into 2 groups. Group 1 (51 patients) with BMI ≥ 30 kg/m 2; Group 2 (32 patients) with BMI <30 kg/m 2. Objectification of symptoms was achieved by using a VAS (visual analogue scale) and index WOMAC. Blood levels of Creactive protein (CRP) and interleukin6 (IL6) also determined. Results: moderate direct relationship between BMI and severity of pain by VAS (r = 356, p = 0,027) was revealed. Excessive body weight (group 2) was established a very close relationship between the change in the index of pain by VAS and difficulties in performing daily activities (B WOMAC) (r = 0,971, p = 0.28). In both groups of patients with OA, regardless of BMI, there was the high level of CRP and IL6. Women with a degenerativedestructive joint disease obtained a very close relationship between IL6 and severity of pain by VAS (r = 0,99; p = 0,23). In patients with OA 2 groups revealed a strong relationship (r = 0,84, p = 0.002) between the rates of CRP and IL6 and significant relationship (r = 0,67, p = 0.006) between these same indicators in women with BMI <30 kg/m 2. Conclusions: The course of OA in women with excessive body weight is accompanied by more marked pain syndrome, increased levels of biomarkers of systemic inflammation, significant functional impairment and frequent development of synoviitis of the knee.

Full Text

ВЛИЯНИЕ МЕТАБОЛИЧЕСКИХ НАРУШЕНИЙ НА ТЕЧЕНИЕ ОСТЕОАРТРОЗА
×

References

  1. Fan Z., Bau B., Yang H. et al. Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with interleukin1beta //Arthritis Rheum. 2005. Vol. 52 (1). P. 136-143.
  2. Yoo S.A., Park B.H., Yoon H.J. et al. Calcineurin modulates the catabolic and anabolic activity of chondrocytes and participates in the progression of experimental osteoarthritis // Arthritis Rheum. 2007. Vol. 56 (7). Р. 2299-2311.
  3. Dandona P., Aljada A.,Chaudhury A. et al. Metabolic Syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation // Circulation. 2005. Vol. 111 (11). Р. 1448-1454.
  4. Grundy S.M. Inflammation, hypertension, and metabolic syndrome // JAMA. 2003. Vol. 290 (22). P. 3000-3002.
  5. Wellen K.E., Hotamisligil G.S. Inflamation, stress, and diabetes // J. Clin. Invest. 2005. Vol. 115 (5). P. 1111-1119.
  6. Altman RD. Measurement of structure (disease) modification in osteoarthritis // Osteoarthritis Cartilage. 2004. Vol. 12. Suppl. A. Р. S69-S76.
  7. Bloomgarden А. Inflammation and insulin resistance // Diabetes Care. 2003. Vol. 26 (5). Р. 1619-1623.
  8. Зубарев А.В. Диагностический ультразвук. Костномышечная система. М.: ООО "Фирма Стром"., 2002 136 с.
  9. McWilliams D.E., Reehana G., Carolyn B. et al. Cartilage oligomezic matrix protein and aggrecan in synovial fluid from patients with osteoarthritis: markers of local or systemic characteristics? // Rheumatology. 2004. Vol. 43. Suppl. 2. P. 68.
  10. Hunter D.J., Niu J., Zhang Y. et al. Knee height, knee pain, and knee osteoarthritis: the Beijing Osteoarthritis Study //Arthritis Rheum. 2005. Vol. 52 (5). P. 1418-1423.
  11. Cicuttini F.M., Teichtahl A.J., Wluka A.E. et al. The relationship between body composition and knee cartilage volume in healthy, middleaged subjects. //Arthritis Rheumatism. 2005. Vol. 52 (2). P. 461-467.
  12. Putz D.M., Goldner W.S., Bar R.S. et al. Adiponectin and Creactive protein in obesity, type 2 diabetes, and monodrug therapy // Metabolism. 2004. Vol. 53 (11). Р. 1454-1461.
  13. Kumar N., Marshall N.J., Neely D. et al. CRP levels are raised in patients with longstanding osteoarthritis when compared with normal controls // Rheumatology. 2004. Vol. 43. Suppl. 2. P. 69.
  14. Belo J.N., Berger M.Y., Reijman M. et al. Prognostic factors of progression of osteoarhtritis of the knee – a systemic factors and disease stage // Ann. Rheam. Dis. Ann. Eur. Congr. of Rheumatology EULAR 2005. Abstracts. Vol.64. Suppl. 111. P. 479.
  15. Agarwal S., Deschner J., Long P. et al. Role of NFkb transcription factors in antiinflammatory and proinflammatory actions of mechanical signals //Arthritis Rheum. 2004. Vol. 50 (11). P. 3541-3548.
  16. Aronson D., Bartha P., Zinder O. et al. Obesity is the major determinant of elevated Creactive protein in subjects with the metabolic syndrome // Int. J. Obes. Relat. Metab. Disord. 2004. Vol. 28 (5). P. 674-679.
  17. Saxne T., Lindell M., MDnsson B et al. Inflammation is a feature of the disease process in early knee joint osteoarthritis // Rheumatology (Oxford). 2003. Vol. 42 (7). P. 903-904.
  18. Ridker P.M., Wilson P.W., Grundy S.M. Should Creactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? // Circulation. 2004. Vol. 109 (23). Р. 2818-2825.
  19. Sharma L. Local factors in osteoarthritis. // Curr. Opin. Rheumatol. 2001. Vol. 13 (5). P. Р. 441-446.
  20. Алексеева Л.И., Зайцева Е.М. Субхондральная кость при остеоартрозе: новые возможности терапии // РМЖ. 2004. Т. 12, № 20 С. 1133-1136.
  21. Bastard J.P., Maachi M., Van Nhieu J.T. et al, Adipose tissue IL6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro // J. Clin. Endocrinol. Metab. 2002. Vol. 87 (5). P. 2084-2089.
  22. Behre C.J., Fagerberg B., HultJn L.M., Hulthe J. The reciprocal association of adipocytokines with insulin resistance and Creactive protein in clinically healthy men // Metabolism. 2005. Vol. 54 (4). Р. 439-444.
  23. Andersson M.L., Saxne T., Petersson I.F. Creactive protein as a marker of developing knee joint osteoarthritis – A 12 year followup // Arthritis Rheum. 2007. Vol. 56 (9). P. 1461-1478.
  24. Yeh E.T. CRP as a mediator of disease // Circulation. 2004. Vol. 109 (21 Suppl. 1): II-114.
  25. Brandt KD., Lohmander S., Doherty M. Pathogenesis of osteoarthritis. Introduction: The concept of osteoarthritis as failure of the diarthrodial joint / In K.D. Brandt, M. Doherty, S. Lohmander (eds.), Osteoarthritis, Second Edition. Oxford: Oxford University Press 2003: Р. 69-71.
  26. Anan F., Takahashi N., Nakagawa M. et al. Highsensivity Creactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients // Metabolism. 2005. Vol. 54 (4). Р. 552-558.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Artemenko N.A., Ter-Ananyants E.A., Mashtalova O.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 38032 от 11 ноября 2009 года.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies